Membrane glycoprotein defects in congenital platelet disorders.
نویسندگان
چکیده
concanavalin A-binding proteins are relatively unaffected by the changes in glucose concentration. At this threshold level of glucose the glucose-regulated proteins of Shui et al. (1977) are not apparent. The reappearance of the 100000-mol.wt. glycoprotein can be correlated with the reappearance of the 95 000-mol.wt. glucosamine-labelled glycoprotein (Fig. 2) and there seems, therefore, good reason to believe that they are linked in some way or involved together in glucose metabolism. The induction of the 100000-mol.wt. glycoprotein is specific for Dglucose and D-mannose at concentrations above 300mg/ litre. L-glucose. deoxy-D-glucose. 5-thio-D-glucose ahd Dgalactose are not inducers, even though deoxy-D-glucose and 5-thio-D-glucose are supposed to enter the cell using the same carrier as D-glucose. Not surprisingly the induction is completely inhibited by cytochalasin B, but is unaffected by cytochalasins A. C or D (Kletzien el al., 1972). It has also been shown that PGI9-G cells grown in low levels of glucose bind only 50% of labelled cytochalasin B compared with the same cells grown in normal levels of glucose, thus providing additional evidence that the glucose carrier protein is much reduced in these cells. Addition of emetine, a specific protein inhibitor, just before glucose is sufficient to completely block the inductive effect, showing that protein synthesis must take place if induction of the 100000-mol.wt. glycoprotein is to occur. Recently it has been demonstrated by radiation-target-size theory that the glucose carrier in human erythrocytes is most likely a protein of mol.wt. 200000 which exists as a dimer of mol.wt.-100000 or a tetramer of mol.wt.-50000 subunits (Jung et al., 1980). Also using a more specific glucose-transport blocking reagent, maltosyl isothiocyanate, Mullins 8c Langdon (1980) confirmed that in the human erythrocyte the glucose carrier is contained in the band 3 proteins (mol.wt. 90000lOO000). It thus seems highly probable that the changes seen in the 100000-rno1.w. and 90000-mol.wt. glycoproteins in malignant transformation are directly related to the glucose uptake by these cells and may well be linked to the glucose-regulated proteins seen by other workers (Shiu et al., 1977; McCormick et al., 1979), but distinct from them, since the former are present in only very small amounts.
منابع مشابه
Experimental study on healing of long bone defects treated with fibrin membrane enriched with platelet growth factors and periosteal mesenchymal stem cells in rabbit: radiographical and histopathological evaluations
The present study was designed to evaluate the effects of platelet growth factors and periosteal mesenchymal stem cells on bone healing process, radiographically. Forty male White New Zealand rabbits in five equal groups were used in this study. A 2 mm full thickness bone defect was made in left radial bone of each animal. In group A (control) the defect was left with no medical intervention. I...
متن کاملIdentification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
This study characterizes a congenital hemorrhagic disorder caused by a platelet function defect with the following features: (1) severely impaired platelet aggregation and fibrinogen or von Willebrand factor (vWF) binding induced by adenosine diphosphate (ADP); (2) defective aggregation, release reaction, and fibrinogen or vWF binding induced by other agonists; (3) normal aggregation and releas...
متن کاملHermansky-Pudlak syndrome
Inherited platelet function disorders (IPFDs) encompass a heterogeneous group of haemorrhagic diseases caused by congenital defects of platelets function affecting various elements of the platelet physiology (membrane receptors, intraplatelet signalling proteins, granules), and leading to different clinical manifestations (1–3). Platelets have three types of secretory granules that differ in th...
متن کاملAnalysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry.
Antibodies that bind to human platelet membrane glycoproteins IIb and IIIa were used to develop methods for analyzing platelet membrane components by flow cytometry. Platelets were tentatively identified by their low-intensity light scatter profiles in whole blood or platelet-rich plasma preparations. Identification of this cell population as platelets was verified by using platelet-specific an...
متن کاملVirally mediated changes in cellular permeability.
syndrome platelets whose surface proteins were labelled with lz5I by the lactoperoxidase-catalysed procedure. A specific absence of radioactivity in the glycoprotein-Ib region of the gel may be observed; the other major membrane glycoproteins are normally labelled. Confirmation of the presence of glycoprotein IIIa was provided by Kunicki et al . (1978), who showed that BernardSoulier-syndrome p...
متن کاملشناسایی 5 جهش جدید در ژن گلیکوپروتئین Ibα پلاکت در بیماران برنارد- سولیر ایران
Background & Aim: Bernard-Soulier syndrome (B.S.S) is a rare hereditary bleeding disorder due to molecular defects of platelet GPIb–IX–V. The GPIb-IX-V complex is composed of four chains of GPIbα, GPIbβ, GPIX and GPV. The largest chain of this complex is GPIbα and is responsible for binding to ligand and most of identified mutations belong to this glycoprotein. The aim of this study was...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Biochemical Society transactions
دوره 8 6 شماره
صفحات -
تاریخ انتشار 1980